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Introduction
Enterococcus faecalis is a normal commensal in the hu-
man and animal gastrointestinal tract but it has became 
increasingly recognised as one of the leading cause of 
nosocomial infections. Urinary tract infections (UTI) 
are the most frequent, although more serious infections, 
such as bacteremia, endocarditis and neonatal infections 
also occur [1]. 
One of the main reasons why enterococci can survive 
in the hospital environment is their resistance to a 
variety of antimicrobials. In fact, in addition to their 
intrinsic resistance to low levels of aminoglycosides, 
cephalosporins, lincosamydes and many β-lactams, 
enterococci are also able to acquire resistance to 
many antibiotics, either by mutation of existing 
chromosomal genes or by transfer of resistance de-
terminants [2]. The past two decades have therefore 
witnessed the rapid emergence of multidrug resistant 
enterococci [3].
In addition to antimicrobial resistance, several putative 
factors that may contribute to enhanced virulence have 
been described in Enterococcus faecalis, although the 
molecular mechanism of virulence is still not complete-
ly understood. Adherence to host cells is considered to 
be a crucial step in the establishment of many bacterial 
infections, and a number of adhesion factors have been 
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identified so far, such as the aggregation substance 
(AS), the endocarditis-associated antigen (EfaA), the 
enterococcal surface adhesin (Ace), the enterococcal 
surface protein (Esp) [4].
Secreted molecules, such as cytolysin and gelatinase, 
have also been indicated as possible virulence fac-
tors [4]. Gelatinase is a Zinc-endopeptidase, co-tran-
scribed with the serine protease and regulated by the 
quorum-sensing fsr locus that can hydrolyze gelatine, 
collagen, casein and other small bioactive peptides. It 
has been shown that Enterococcus faecalis strains that 
contain fsr knockouts have diminished virulence both in 
mammalian [5] and Caenorhabditis elegans model [6]. 
Cytolysin is a bacterial toxin with haemolytic and bac-
teriolytic activity. The Enterococcus faecalis cytolysin 
operon has been characterized and the regulation of 
cytolysin expression described [7, 8].
It has been hypothesized that the presence of specific 
genes associated with virulence or invasiveness might 
enhance the ability of nosocomial enterococci to colo-
nise hospitalized patients, but conflicting observations 
have been reported. 
The purposes of this study were to define the antibiotic 
resistance pattern and to investigate the presence of 
genes encoding several virulence factors in Entero-
coccus faecalis strains isolated from different human 
clinical sources in Sardinia. The possible correlations 
Summary
In this study, the antibiotic resistance pattern and the presence 
of genes encoding several virulence factors in 91 Enterococcus 
faecalis strains isolated from different human clinical sources in 
Sardinia were investigated. Genotypic determination of virulence 
genes (gelE, esp, agg, ace, cylA,B,M,LL,LS, efaA, fsrB) was car-
ried out by PCR. The production of gelatinase and haemolytic 
activity were also determined. Antimicrobial susceptibility tests 
were performed by an automated microdilution test (Vitek). The 
strains examined in this study contained at least one and up to as 
many as all virulence genes investigated. Examining the distribu-
tion of these factors in the different groups of clinical strains, 
we found that all but one virulence determinant were detected 
more frequently among urinary isolates. The detection of some 
factors by PCR did not always correlate with its phenotypic 
expression. Antibiotic susceptibilities among the Enterococcus 
faecalis strains investigated in our study were typical for the 
species, with expected levels of acquired resistance. Faecal iso-
lates had the highest percentage of resistance, especially to high 
level-gentamicin, ciprofloxacin and norfloxacin. In summary, 
a wide variety of genes encoding virulence factors have been 
detected among our clinical Enterococcus faecalis strains, and 
those isolated from UTI were characterized by a higher virulence 
potency compared with strains from other clinical sources. Silent 
virulence genes (cyl or gelE) were frequently detected, therefore 
both the genotypic and phenotypic assays seem necessary for a 
better characterization of the strains. Our results may serve as 
a basis for additional surveillance studies of infections caused 
by this microorganism.
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between the determinants possessed by the strains and 
their source of isolation were also investigated.
Methods
Clinical isolates
The Enterococcus faecalis strains analysed in this study 
were isolated from 91 patients (one isolate from each 
patient) attended at the Binaghi Hospital of Cagliari 
(Italy) and had the following sources: 55 from urine 
(patients with UTI), 20 from respiratory tract (pharyn-
geal swabs, bronchoalveolar lavage) and 16 from faeces 
(colonized patients).
The isolates were identified to species level using an 
automated system (Vitek, bioMérieux, Rome, Italy) 
as recommended by the manufacturer. To confirm 
the phenotypic identification, a PCR was performed 
with primers specific for the Enterococcus faecalis 
species [9]. All strains were stored at -20°C in 20% 
glycerol-BHI broth.
Antimicrobial susceptibility tests
Antimicrobial susceptibility tests were performed by an 
automated microdilution test (Vitek, bioMérieux), ac-
cording to the manufacturer’s instructions. Antimicrobi-
als tested are reported in Table I.
Interpretation of results was according to CLSI (Clinical 
and Laboratory Standards Institute, formerly National 
Committee for Clinical Laboratory Standards) guide-
lines [10]. Isolates showing intermediate levels of sus-
ceptibility were classified as resistant.
Detection of haemolytic and gelatinase 
activity
Haemolytic activity was determined on Columbia 
Blood agar (Microbiol, Cagliari, Italy) plates supple-
mented with 5% defibrinated horse blood after 48 h 
of incubation at 37°C in anaerobiosis. β-haemolysis 
was indicated by a clear zone of hydrolysis around the 
colonies.
Production of gelatinase was tested on Todd-Hewitt agar 
(Microbiol) containing 30 g gelatine (Sigma, Milan, 
Italy) per liter. Plates were incubated overnight at 37°C, 
then placed at 4°C for 6 h before examination for zones 
of turbidity around the colonies, indicating hydrolysis.
PCR detection of virulence genes 
The following virulence genes: gelE (gelatinase), esp 
(enterococcal surface protein), ace (enterococcal surface 
adhesion), agg (aggregation substance), the cytolysin 
operon (cylA,B,M,LL,LS), efa A (Enterococcus faecalis 
antigen A) and fsrB for fsr locus were amplified by PCR 
using published specific primers and conditions (Tab. 
I). The strains with gelE genotype but not producing 
gelatinase activity were examined for the presence of a 
23.9 kb deletion segment corresponding to the fsr gene 
cluster upstream of gelE by PCR using the primer set 
and amplification conditions described by Nakayama 
et al. [11].
Oligonucleotides were synthesized by a custom primer 
service (BSC Biotech, Sardinia, Italy). Template DNA 
was extracted using a synthetic resin (Instagene, Bio-
Rad, Melville, NY) according to the manufacturer. Am-
plification reactions were performed in a Mastercycler 
gradient 5331 (Eppendorf). 
Statistical analysis
Categoric analysis was done by the χ2 method with 
Yates’s correction, where appropriate, with significance 
limits posed at P < 0.05. 
Results
Antimicrobial susceptibility tests
The comparative in vitro antimicrobial activities of the 
13 agents investigated are shown in Table II. All strains, 
regardless of their origin, were susceptible to ampicillin, 
teicoplanin and nitrofurantoin. The majority were resist-
ant to tetracycline and fosfomycin, while only three (one 
from each site of isolation) to vancomycin, although 
they were susceptible to teicoplanin. 
Sensitivity rates to the other agents tested showed a 
certain variability according to the site of isolation. Fae-
ces strains were considerably more resistant than those 
from other sources, showing elevated resistance rates to 
fluoroquinolones and high-level gentamycin (P < 0.05 
Tab. I. pcr primers used for detection of virulence determinants in 
enterococcus faecalis strains.
Gene Primer Sequence (5’ to 3’)
Product 
size (bp)
Reference
ace f2
r3
gagcaaaagttcaatcgttgac
gtctgtcttttcacttgtttct
1,003 [31]
agg agg1
agg2
aagaaaaagaagtagaccaac
aaacggcaagacaagtaaata
1,553 [19]
cylM te13
te14
ctgatggaaagaagatagtat
tgagttggtctgattacattt
742 [19]
cylB te15
te16
attcctacctatgttctgtta
aataaactcttcttttccaac
843 [19]
cylA te17
te18
tggatgatagtgataggaagt
tctacagtaaatctttcgtca
517 [19]
cylLL cyLL1
cyLL2
gatggagggtaagaattatgg
gcttcacctcactaagttttatag
253 [8]
cylLS cyLs1
cyLs2
gaagcacagtgctaaataagg
gtataagagggctagtttcac
240 [8]
efaA efa1
efa2
gacagaccctcacgaata
agttcatcatgctgtagta
705 [19]
fsrB B1
B2
atgctaatcgattggattctaaaa
tctttttaggtttttcagtttgtc
710 [11]
gelE geL1
geL2
accccgtatcattggttt
acgcattgcttttccatc
419 [19]
esp esp11
esp12
ttgctaatgctagtccacgacc
gcgtcaacacttgcattgccgaa
933 [22]
ef1841/
fsrC
ef1841
fsrc
gatcaagaagggaagccacc
ccaaccgtgctcttctgga
1050 [11]
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vs urine). Isolates from respiratory tract and urine were 
fully susceptible to piperacillin and imipenem, and 
showed a low degree of resistance to fluoroquinolones 
and high-level amynoglycosides. Only five urine strains 
were resistant to penicillin G.
Although 89% of isolates presented multidrug resistance, 
i.e. resistance to two or more drugs, only four isolates 
(three from faeces and one from urine) were resistant 
to all agents tested, the majority being resistant to two 
(30%) or five (19%). Interestingly, resistance to tetracy-
cline and fosfomycin was always associated (17 strains 
from urine, 12 from faeces, 8 from respiratory tract) and 
all strains resistant to ciprofloxacin were also resistant to 
norfloxacin, suggesting the possibility of gene linkage, 
although this was not confirmed in our study.
PCR detection of virulence genes
The results of PCR amplification of the putative viru-
lence genes tested are reported in Table III. All genes 
were always detected in higher percentages in urine 
isolates, except for esp, which was recovered in higher 
but not significantly different percentage in strains from 
respiratory tract. A characteristic distribution in number 
of virulence factors could be noted. Isolates from UTI 
possessed between one (3.6%) and all seven (12.7%) 
determinants, with the majority (23.6%) having six, 
while strains from faeces and respiratory tract usually 
carried four factors (data not shown).
According to the type of factor, no distinct pattern could 
be observed but we found that 84% of positive ace 
strains were associated with gelE gene and 60% of posi-
tive cylM strains also possessed agg factor.
As for adhesins, efaA was detected in almost all isolates 
(96.7%), pointing to the widespread occurrence of this 
adhesion-associated factor in Enterococcus faecalis. 
The second most frequent adherence factor was ace 
(67%) followed by esp (52.7%), while agg, coding for 
the aggregation substance (AS), was detected in 42.8% 
of the strains. 
After efaA, gelE represented the second most com-
mon factor, being present in 68% of total isolates. Of 
the determinants involved in the production of func-
tional cytolysin, cylM, whose product is involved in 
the post-translational modification of cytolysin, was the 
most commonly recovered (38.5% of total strains). As 
shown in Table IV, the whole operon cylLLLSMBA+ was 
Tab. II. antimicrobial resistance in enterococcus faecalis isolates according to the site of isolation.
N (%) of resistant strains
Antibiotic Urine
n = 55
Respiratory tract
n = 20
Faeces
n = 16
Total 
n = 91
ampicillin 0 0 0 0
penicillin g 5 (9) 0 2 (12.5) 7 (7.7)
piperacillin 0 0 1 (6) 1 (1.1)
imipenem 0 0 1 (6) 1 (1.1)
gentamicin* 17 (31)** 8 (40) 12 (75) 37 (41)
streptomycin* 23 (42) 6 (30) 4 (25) 33 (36)
ciprofloxacin 17 (31)** 8 (40) 12 (75) 37 (41)
norfloxacin 17 (31)** 8 (40) 12 (75) 37 (41)
vancomycin 1 (1.8) 1 (5) 1 (6) 3 (3.2)
teicoplanin 0 0 0 0
tetracycline 48 (87) 17 (85) 16 (100) 81 (89)
fosfomycin 52 (94.5) 20 (100) 15 (94) 87 (95.6)
nitrofurantoin 0 0 0 0
* high-level
** p < 0.05 vs faeces
Tab. III. presence of putative virulence genes in enterococcus faecalis strains according to the site of isolation.
N (%) of isolates
Virulence factor Urine
n = 55
Respiratory tract
n = 20
Faeces
n = 16
Total
n = 91 
efaA 55 (100) 19 (95) 14 (87.5) 88 (96.7)
ace 42 (76) 11 (55) 8 (50) 61 (67)
agg 28 (51) 7 (35) 4 (25) 39 (42.8)
esp 28 (51) 12 (60) 8 (50) 48 (52.7)
cylM 30 (54.5) 3 (15) 2 (12.5) 35 (38.5)
cylB 9 (16.4) 3 (15) 2 (12.5) 14 (15.4)
cylA 19 (34.5) 3 (15) 2 (12.5) 24 (26.4)
cylLL 21 (38.2) 3 (15) 2 (12.5) 26 (28.6)
cylLS 7 (12.7) 3 (15) 2 (12.5) 12 (13.2)
gelE 41 (74.5) 12 (60) 9 (56) 62 (68)
fsrB 30 (54.5) 10 (50) 6 (37.5) 46 (50.5)
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detected in 12 isolates (seven from urine, three from 
respiratory tract and two from faeces). Genotypes with 
at least one gene were found in 26 urine isolates, while 
no cyl genes were detected in 53 strains (58%), with a 
significantly higher number of negative isolates among 
faeces and respiratory tract versus urine isolates (87.5, 
85 and 40% respectively). Comparison of β-haemolysis 
and detection of cyl genes revealed that cytolysin deter-
minants behave as silent in six non haemolytic urinary 
isolates. 
Since the presence of gelE gene was also not always 
correlated with its expression, and fsr genes were shown 
to positively regulate the expression of gelatinase in En-
terococcus faecalis [11, 12], we investigated the pres-
ence of a chromosomal deletion in the fsr gene cluster 
region upstream to gelE. As can be seen in Table V, of 
the 62 gelE positive strains 41, also possessing the fsrB 
gene, produced gelatinase. Among the 50 gelatinase 
negative strains, in 11 having gelE but lacking fsrB, the 
1 kb PCR product corresponding to the 3’ end of ef1841 
and 3’ end of the fsrC was detected, indicating the pres-
ence of the 23.9 kb deletion sequence; 29 isolates lacked 
both gelE and fsrB, suggesting the presence of an even 
larger deletion and in five fsrB- gelE+ strains the internal 
ef1841/fsrC product was not detected, presumably indi-
cating a defective fsr gene cluster.
Discussion
In recent years, enterococci have received an increas-
ing attention because of the development of resistance 
to multiple antimicrobial drugs and their common 
prevalence as nosocomial pathogens. In the case of 
Enterococcus faecalis, which is the third most common 
hospital pathogen, increased antibiotic resistance would 
likely result in increased mortality [13]. Antibiotic re-
sistance may be considered to be both the cause and the 
effect of the adaptation of certain isolates to hospital 
environment, and the most likely antibiotics involved 
in this phenomenon are probably gentamicin and fluo-
roquinolones.
In our study, Enterococcus faecalis faecal isolates had 
the highest percentage of resistance, especially to high 
level-gentamicin, ciprofloxacin and norfloxacin. The 
percentage of faecal isolates showing HLR to gen-
tamicin in this study is much higher (75%) than the val-
ue of 25% reported by d’Azevedo et al. [14] but similar 
to that found by Ruiz-Garbajosa et al. [15] among faecal 
ICU isolates (65.5%).
Although a major concern in our findings could be 
the presence of strains harbouring multiple antibiotic 
resistance, the elevated sensitivity rates to β-lactams 
and glycopeptides deserve particular attention. The low 
level of vancomycin resistance observed in our study 
(3% of total strains) confirms the only available data in 
literature for Sardinia [16], and is probably related to a 
rational use of vancomycin in the hospital from which 
the strains were isolated. Similar rates of glycopeptide 
resistance have been reported for Enterococcus faecalis 
strains isolated in Italy and Europe [17, 18]. 
Over the past few years, several studies have been fo-
cused on the putative virulence factors of enterococci of 
clinical, environmental and food origin. In general, the 
occurrence of virulence genes in Enterococcus faecalis 
strains varied widely from one study to another, proba-
bly due to the difference in their clinical and geographic 
origins. Most of these epidemiological studies have 
been carried out by PCR, which is widely used for rapid 
screening of the isolates. 
The strains examined in this study contained at least one 
and up to as many as all virulence genes investigated. 
Examining the distribution of these factors in the differ-
ent groups of clinical strains, we found that all but one 
Tab. IV. correlation between the presence of the cyl operon genes 
and the detection of haemolysis in clinical strains of enterococcus 
faecalis from different sources.
Source 
of isolates
Presence of genes 
of the cyl operon
Number 
of isolates
β-haemolysis
positive* negative*
Urine (n = 55) all set 7 7 -
at least one cyl 26 20 6
cyl not detected 22 - 22
respiratory 
tract (n=20)
all set 3 3 -
at least one cyl 0 - -
cyl not detected 17 - 17
faeces (n=16) all set 2 2 -
at least one cyl 0 - -
cyl not detected 14 - 14
* number of isolates
Tab. V. phenotypes and genotypes related to fsr regulated gelatinase production in clinical isolates of Enterococcus faecalis from different 
sources.
N (%) of isolates
Gelatinase Gelatinase negative
Source of isolates Positive* fsrB- gelE- fsrB- gelE+
ef1841/fsrC+
fsrB- gelE+
ef1841/fsrC -
fsrB+ gelE+
Urine (n = 55) 30 (54.5) 14 (25) 9 (16) 2 (3.6) 0
respiratory tract 
(n = 20)
9 (45) 8 (40) 1 (5) 1 (5) 1 (5)
faeces (n = 16) 2 (12.5) 7 (43.7) 1 (6.2) 2 (12.5) 4 (25)
total n (%) of isolates 41 (45) 29 (31.8) 11 (12) 5 (5.4) 5 (5.4)
* isolates having fsrB+ gele+ genotype and gelatinase activity
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virulence determinant, namely esp, were detected more 
frequently among urinary isolates. The high incidence 
of multiple virulence factors in urinary strains could 
potentially contribute to facilitate bacterial colonization 
and pathogenesis of Enterococcus faecalis in the urinary 
tract. 
The very common occurrence of efaA is in agreement 
with previous findings [19, 20]. Surprisingly, in our 
study the occurrence of esp was not significantly associ-
ated with UTI isolates, although a role of Esp protein as 
urovirulence factor has been demonstrated [21]. How-
ever, the percentage of strains bearing esp was similar 
to that reported in other studies for Enterococcus faeca-
lis [16, 18, 20]. Since the first studies on esp and its role 
in bacterial adhesion have been published [22, 23], sev-
eral conflicting results have been reported. Tendolkar 
et al. [24] compared isogenic esp-positive and esp-de-
ficient strains and found that esp leads to a significant 
increase in biofilm formation. However, Hällgren et 
al. [25] demonstrated that in vitro adherence to urinary 
tract catheters was indipendent by esp, and Kristich et 
al. [26] demonstrated that in vitro biofilm formation can 
occur in absence of esp while it is enhanced by GelE. 
Among the cyl operon genes, cylM was present in 38.5% 
of total strains but was particularly associated with urinary 
isolates (56.5%), in accordance with the study of Creti et 
al. [20]. Reports on the incidence of these traits in Ente-
rococcus faecalis have been contradictory; some indicate 
a low prevalence in isolates from food [27] or faeces 
of volunteers [28], whereas others have found a similar 
prevalence in both clinical and food strains [19]. To our 
knowledge this is the first study reporting the occurrence 
of the cytolysin operon genes in Italian clinical isolates. 
The observed incidence of agg was lower than previ-
ously reported [19, 29]. Nevertheless, considering the 
existence of functional synergy between cytolysin and 
AS [30] and taking into account the physical cluster-
ing of cyl genes and adhesins genes, some supporting 
evidence for our findings can be found in the similar 
incidence of agg and cyl determinants in our strains.
As for the correlation between phenotypic and geno-
typic tests, in our study the detection of some factors by 
PCR did not always correlate with the phenotypic ex-
pression. We observed an 100% cytolysin phenotypic-
genotypic congruence in strains carrying (12) or lacking 
(53) the whole operon, while in six phenotipically nega-
tive urinary isolates we found at least one of the genes 
investigated. In addition, 20 urinary strains produced 
β-haemolysis even if they did not possess the whole 
operon. Evidence for cyl gene variability due to genetic 
rearrangements was observed in other studies [8, 19]. 
Concerning gelatinase activity, the high frequency of 
apparently silent gelE genes among our isolates could 
be correlated with the loss of one or more genes of the 
fsr operon involved in the regulation of gelE expression, 
as reported by Nakayama et al. [11].
Conclusions
In summary, a wide variety of genes encoding viru-
lence factors have been detected among our clinical 
Enterococcus faecalis strains, and those isolated from 
UTI were characterized by a higher virulence potency 
compared with strains from other clinical sources. Silent 
virulence genes (cyl or gelE) were frequently detected, 
therefore both the genotypic and phenotypic assays seem 
necessary for a better characterization of the strains. Our 
results may serve as a basis for additional surveillance 
studies of infections caused by this microorganism. 
REFERENCES
[1] Moellering MC. Emergence of Enterococcus as a significant 
pathogen. Clin Infect Dis 1992;14:1173-6.
[2] Mundy LM, Sahm DF, Gilmore M. Relationships between 
enterococcal virulence and antimicrobial resistance. Clin 
Microbiol Rev 2000;13:513-22.
[3] Arias CA, Murray BE. Emergence and management of drug 
resistant enterococcal infections. Expert Rev Anti Infect Ther 
2008;6:637-55.
[4] Koch S, Hufnagel M, Theilacker C, et al. Enterococcal infec-
tions: host response, therapeutic and prophylactic possibilities. 
Vaccine 2004;22:822-30.
[5] Qin X, Singh KV, Weinstock GM, et al. Effects of Enterococ-
cus faecalis fsr genes on production of gelatinase and a serine 
protease and virulence. Infect Immun 2000;68:2579-86.
[6] Garsin DA, Sifri CD, Mylonakis E, et al. A simple model 
host for identifying Gram-positive virulence factors. PNAS 
2001;98:10892-97.
[7] Coburn PS, Gilmore MS. The Enterococcus faecalis cytolysin: 
a novel toxin active against eukaryotic and prokaryotic cells. 
Cell Microbiol 2003;5:661-9.
[8] Semedo T, Santos MA, Martins P, et al. Comparative study us-
ing type strains and clinical and food isolates to examine hemo-
lytic activity and occurrence of the cyl operon in enterococci. J 
Clin Microbiol 2003;41:2569-76.
[9] Dutka-Malen S, Evers S, Courvalin P. Detection of glycopep-
tide resistance genotypes and identification to the species level 
of clinically relevant enterococci by PCR. J Clin Microbiol 
1995;33:24-7.
[10] NCCLS. Methods for dilution antimicrobial susceptibility tests 
for bacteria that grow aerobically, 5th edn. Approved standard 
M7-A5. NCCLS, Villanova, PA, 2000.
[11] Nakayama J, Kariyama R, Kumon H. Description of a 23.9-
Kilobase chromosomal deletion containing a region encoding 
fsr genes which mainly determines the gelatinase-negative 
phenotype of clinical isolates of Enterococcus faecalis in urine. 
Appl Environ Microbiol 2002;68:3152-5.
[12] Qin X, Singh KV, Weinstock GM, Murray BE. Characteriza-
tion of fsr, a regulator controlling expression of gelatinase and 
serine protease in Enterococcus faecalis OG1RF. J Bacteriol 
2001;183:3372-82.
[13] Segreti J. Efficacy of current agents used in the treatment of 
Gram-positive infections and the consequences of resistance. 
Clin Microbiol Infect 2005;11:29-35.
[14] d’Azevedo PA, Dias CA, Teixeira LM. Genetic diversity and 
antimicrobial resistance of enterococcal isolates from Southern 
region of Brazil. Rev Inst Med Trop Sao Paulo 2006;48:11-6.
[15] Ruiz-Garbajosa P, Canton R, Pintado V, et al. Genetic and phe-
notypic differences among Enterococcus faecalis clones from 
intestinal colonisation and invasive disease. Clin Microbiol 
Infect 2006;12:1193-8.
s. cosentino et aL.

[16] Dupré I, Zanetti S, Schito AM, et al. Incidence of virulence de-
terminants in clinical Enterococcus faecium and Enterococcus 
faecalis isolates collected in Sardinia (Italy). J Med Microbiol 
2003;52:491-8.
[17] Schouten M, Hoogkamp-Korstanje J, Meis J, et al. Prevalence 
of vancomycin-resistant enterococci in Europe. Eur J Clin 
Microbiol Infect Dis 2000;19:812-22.
[18] Walecka E, Bania J, Dworniczek E, et al. Genotypic charac-
terization of hospital Enterococcus faecalis strains using mul-
tiple-locus variable number tandem-repeat analysis. Lett Appl 
Microbiol 2009;49:79-84.
[19] Eaton TJ, Gasson MJ. Molecular screening of Enterococcus 
virulence determinants and potential for genetic exchange 
between food and medical isolates. Appl Environ Microbiol 
2001;67:1628-35.
[20] Creti R, Imperi M, Bertuccini L, et al. Survey for virulence de-
terminants among Enterococcus faecalis isolated from different 
sources. J Med Microbiol 2004;53:13-20.
[21] Shankar N, Lockatell CV, Baghdayan AS, et al. Role of Ente-
rococcus faecalis surface protein esp in the pathogenesis of as-
cending urinary tract infection. Infect Immun 2001;69:4366-72.
[22] Shankar V, Baghdayan AS, Huycke MM, et al. Infection-
derived Enterococcus faecalis strains are enriched in esp, 
a gene encoding a novel surface protein. Infect Immun 
1999;67:193-200.
[23] Toledo-Arana A, Valle J, Solano C, et al. The enterococcal sur-
face protein, esp, is involved in Enterococcus faecalis biofilm 
formation. Appl Environ Microbiol 2001;67:4538-45.
[24] Tendolkar PM, Baghdayan AS, Gilmore MS, et al. Enterococ-
n	 Received on October 19, 2009. Accepted on February 25, 2010.
n	 Correspondence: Sofia Cosentino, Department of Experimental 
Biology, section of Hygiene, Cittadella Universitaria, SS 554 bivio 
Sestu, 09042 Monserrato (CA) Italy - Tel. +39 0706754146  - Fax 
+39 0706754197 - E-mail: scosenti@unica.it
cal surface protein, Esp, enhances biofilm formation by Ente-
rococcus faecalis. Infect Immun 2004;72:6032-9.
[25] Hällgren A, Claesson C, Saeedi B, et al. Molecular detection 
of aggregation substance, enterococcal surface protein, and 
cytolysin genes and in vitro adhesion to urinary catheters of 
Enterococcus faecalis and E. faecium of clinical origin. Int J 
Med Microbiol 2009;299:323-32.
[26] Kristich CJ, Li YH, Cvitkovitch DG, et al. Esp-independ-
ent biofilm formation by Enterococcus faecalis. J Bacteriol 
2004;186:154-63.
[27] Franz CMAP, Muscholl-Silberhorn AB, Yousif NMK, et 
al. Incidence of virulence factors and antibiotic resistance 
among enterococci isolated from food. Appl Environ Microbiol 
2001;67:4385-9.
[28] Lempiäinen H, Kinnunen K, Mertanen A, et al. Occurrence 
of virulence factors among human intestinal enterococcal iso-
lates. Lett Appl Microbiol 2005;41:341-4.
[29] Semedo T, Santos MA, Lopes MFS, et al. Virulence factors in 
food, clinical and reference enterococci: a common trait in the 
genus? Syst Appl Microbiol 2003;26:13-22.
[30] Chow J, Thal L, Perri M, et al. Plasmid-associated hemolysin 
and aggregation substance production contribute to virulence 
in experimental enterococcal endocarditis. Antimicrob Agents 
Chemother 1993;37:2474-7.
[31] Nallapareddy SR, Singh KV, Duh RW, et al. Diversity of ace, 
a gene encoding a microbial surface component recognizing 
adhesive matrix molecules, from different strains of enterococ-
cus faecalis and evidence for production of ace during human 
infections. Infect Immun 2000;68:5210-7.
